Filing identity and reporting period
Material metadata mismatch: The request identifies AYTU Biopharma, Inc., but the supplied filing is for Rosewind Corporation, a development-stage sailing-school company—not a biotech company. The filing reports the unaudited quarter ended November 30, 2011 (Rosewind fiscal 2012 Q1) and was signed December 23, 2011. The figures below summarize the supplied filing and should not be attributed to AYTU.
Business context and key financial metrics
Rosewind intended to operate an offshore sailing school. It reported no revenue in the quarter and $1,750 in revenue since inception. The company said it had completed training voyages with two students, but only one generated tuition revenue.
| Metric | Quarter ended Nov. 30, 2011 | Comparable 2010 quarter |
|---|---|---|
| Revenue | $0 | $0 |
| Operating expenses | $18,876 | $16,551 |
| Operating loss | $(18,876) | $(16,551) |
| Interest expense | $(791) | $(1,164) |
| Net loss | $(19,667) | $(17,715) |
| Basic and diluted loss per share | $(0.00), as reported | $(0.01), as reported |
| Net cash used in operating activities | $(11,011) | $(11,883) |
At November 30, 2011, cash was $1,717, current assets were $1,870, and current liabilities were $66,444, producing a working-capital deficit of $64,574. Total assets were $18,819; total liabilities were $66,444; and shareholders’ deficit was $47,625. Current liabilities included $55,048 in loans payable to a related party and $5,941 in related-party accrued interest. The loan carried 6% interest, was due on demand, and was secured by the sailing vessel. No operating margin is meaningful because quarterly revenue was zero.
Cash declined by $2,276 during the quarter: operating activities used $11,011, investing activities used $0, and financing activities provided $8,735, including $5,987 from stock issuance and net related-party loan proceeds of $2,748.
Material changes versus the prior comparable period
Net loss increased by $1,952, or 11%, from the prior-year quarter. Operating expenses rose by $2,325. Professional fees increased $883 to $8,434, which management attributed primarily to higher audit fees; related-party contributed services increased $750 to $1,650, attributed to yacht maintenance and annual-report preparation. Interest expense decreased by $373. Revenue remained zero.
Outlook, risks, and unusual items
- Management cited continuing losses, limited operating history, and uncertainty about the company’s ability to continue as a going concern. It intended to seek additional funding, including equity financing, but gave no assurance that funding would be available.
- The filing estimated existing cash could sustain operations for a maximum of two months from the report date. It also warned that annual public-company costs could exceed $25,000.
- Principal risks included failure to attract paying students, dependence on additional financing, potential shareholder dilution, reliance on a sole officer/director, vessel safety and maintenance, possible regulatory or licensing requirements, and limited insurance coverage.
- The company reported $1,650 of officer-contributed services and rent during the quarter. It issued 39,910 common shares for $5,987 in cash.
- Management stated disclosure controls were effective and reported no material change in internal controls over financial reporting. The filing provided no quantified revenue or profitability guidance.
Most important facts for an investor to verify
- Confirm the issuer: the supplied filing is Rosewind Corporation, not AYTU Biopharma, Inc.
- Verify the reported cash runway, financing needs, and the terms and demand status of the $55,048 related-party loan.
- Reconcile an apparent share-count/subsequent-event inconsistency: the equity statement includes a 490,654-share conversion of a related-party note dated December 10, 2011, while the balance sheet reports 4,774,568 shares at November 30 and the subsequent-events note says there were no events to report.
- Confirm vessel location and related asset-risk disclosures: the filing identifies Port Townsend, Washington, but also discusses recovery risks involving a vessel in foreign jurisdictions.
- Check the student, revenue, and operating-history disclosures against underlying records; the filing describes two students but only $1,750 of lifetime revenue and no quarterly revenue.